Breakthrough anti-HIV drug "lenacapavir" by Gilead Sciences deployed in African countries
|
Zimbabwe has taken a groundbreaking step in its fight
against HIV by launching the administration of lenacapavir, a
long-acting injectable HIV ... |
New approach to HIV treatment offers hope to reduce daily drug needs
More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the ... View article...